| 2026-02-05 09:45 | UU:DSS | | News Release200 | DSS, Inc. Announces Closing of $1.0 Million Underwritten Public Offering |
| 2026-02-04 08:35 | UU:DSS | | News Release200 | DSS, Inc. Announces Pricing of $1.0 Million Underwritten Public Offering |
| 2026-02-03 20:17 | UU:DSS | | News Release200 | DSS, Inc. Announces Launch of Proposed Public Offering |
| 2025-06-24 08:30 | UU:DSS | | News Release200 | DSS, Inc.'s Subsidiary, Impact BioMedical Inc., Announces Strategic Merger |
| 2025-05-22 08:31 | UU:DSS | | News Release200 | DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth |
| 2025-04-24 08:30 | UU:DSS | | News Release200 | Sentinel Brokers Company, Inc., a Subsidiary of DSS, Inc., Receives FINRA Approval to Act as Underwriter and Selling Group Member for Corporate Securities Offerings |
| 2025-02-26 08:30 | UU:DSS | | News Release200 | DSS, Inc. Announces Sale of Celios(TM) to Impact BioMedical, Streamlining Portfolio for Strategic Growth |